Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Charlene Smith-Geater

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Nature Neuroscience|December 12, 2022
An RNA-targeting CRISPR-Cas13d system alleviates disease-related phenotypes in Huntington's disease modelsKathryn H Morelli, Qian Wu, Maya L Gosztyla, et al.
Journal of Virology|December 22, 2021
Microglia Do Not Restrict SARS-CoV-2 Replication following Infection of the Central Nervous System of K18-Human ACE2 Transgenic MiceGema M Olivarria, Yuting Cheng, Susana Furman, et al.
Biorxiv : the Preprint Server for Biology|November 24, 2021
Microglia do not restrict SARS-CoV-2 replication following infection of the central nervous system of K18-hACE2 transgenic miceGema M Olivarria, Yuting Cheng, Susana Furman, et al.
Stem Cell Reports|February 29, 2020
Aberrant Development Corrected in Adult-Onset Huntington's Disease iPSC-Derived Neuronal Cultures via WNT Signaling ModulationCharlene Smith-Geater, Sarah J Hernandez, Ryan G Lim, et al.
Nature Communications|February 8, 2023
CryoET reveals organelle phenotypes in huntington disease patient iPSC-derived and mouse primary neuronsGong-Her Wu, Charlene Smith-Geater, Jesús G Galaz-Montoya, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 20, 2021
PIAS1 modulates striatal transcription, DNA damage repair, and SUMOylation with relevance to Huntington's diseaseEva L Morozko, Charlene Smith-Geater, Alejandro Mas Monteys, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Nature Neuroscience|December 12, 2022
An RNA-targeting CRISPR-Cas13d system alleviates disease-related phenotypes in Huntington's disease modelsKathryn H Morelli, Qian Wu, Maya L Gosztyla, et al.
Journal of Virology|December 22, 2021
Microglia Do Not Restrict SARS-CoV-2 Replication following Infection of the Central Nervous System of K18-Human ACE2 Transgenic MiceGema M Olivarria, Yuting Cheng, Susana Furman, et al.
Biorxiv : the Preprint Server for Biology|November 24, 2021
Microglia do not restrict SARS-CoV-2 replication following infection of the central nervous system of K18-hACE2 transgenic miceGema M Olivarria, Yuting Cheng, Susana Furman, et al.
Stem Cell Reports|February 29, 2020
Aberrant Development Corrected in Adult-Onset Huntington's Disease iPSC-Derived Neuronal Cultures via WNT Signaling ModulationCharlene Smith-Geater, Sarah J Hernandez, Ryan G Lim, et al.
Nature Communications|February 8, 2023
CryoET reveals organelle phenotypes in huntington disease patient iPSC-derived and mouse primary neuronsGong-Her Wu, Charlene Smith-Geater, Jesús G Galaz-Montoya, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 20, 2021
PIAS1 modulates striatal transcription, DNA damage repair, and SUMOylation with relevance to Huntington's diseaseEva L Morozko, Charlene Smith-Geater, Alejandro Mas Monteys, et al.
Pageof 1